Posts

Track 18: Blood Cancer – Advancing Research, Diagnosis, and Treatment at the 13th International Cancer and Medical Oncology Conference and Exhibition

Image
  Blood cancer remains one of the most complex and impactful areas of oncology, affecting the production and function of blood cells and posing significant challenges in diagnosis, treatment, and long-term patient care. Track 18: Blood Cancer at the 13th International Cancer and Medical Oncology Conference and Exhibition , taking place on February 1–2, 2027 at Novotel Al Barsha, Dubai, UAE , is designed to bring together hematologists, oncologists, researchers, clinicians, academicians, and healthcare innovators to discuss the latest breakthroughs in hematologic malignancies and precision oncology. The conference offers participants a global platform for scientific exchange, networking, and professional development, along with eligibility for 30 CME/CPD Credits for qualified attendees. About Track 18: Blood Cancer Track 18 focuses on cancers that affect the blood, bone marrow, and lymphatic system, including: Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myelopro...

Track 17: Skin Cancer at the 13th International Cancer and Medical Oncology Conference and Exhibition

Image
  Skin cancer remains one of the most prevalent malignancies worldwide, with rising incidence rates and evolving treatment approaches transforming clinical practice. Track 17: Skin Cancer at the 13th International Cancer and Medical Oncology Conference and Exhibition , scheduled for February 1–2, 2027 at Novotel Al Barsha, Dubai, UAE , offers an important scientific platform for oncologists, dermatologists, surgeons, researchers, pathologists, and healthcare professionals to discuss the latest breakthroughs in skin cancer prevention, diagnosis, treatment, and survivorship. The conference will be conducted in a hybrid format , allowing both onsite and virtual participation for global attendees. About Track 17: Skin Cancer Skin cancer includes a broad spectrum of malignancies such as melanoma, basal cell carcinoma (BCC), squamous cell carcinoma (SCC), Merkel cell carcinoma, and rare cutaneous malignancies . Advances in molecular oncology, immunotherapy, targeted therapy, dermato...

Track 16: Prostate Cancer 13th International Cancer and Medical Oncology Conference and Exhibition

Image
  February 1–2, 2027 | Novotel Al Barsha, Dubai, UAE The 13th International Cancer and Medical Oncology Conference and Exhibition brings together leading oncologists, researchers, clinicians, pathologists, healthcare innovators, academicians, and industry professionals from across the globe to discuss the latest advancements in cancer care, diagnostics, therapeutics, and translational oncology. The conference will be hosted at the prestigious Novotel Al Barsha in Dubai, UAE. Among the major scientific sessions, Track 16: Prostate Cancer highlights groundbreaking developments in prostate cancer biology, precision diagnostics, molecular therapeutics, immunotherapy, radiation oncology, robotic surgery, survivorship care, and personalized medicine approaches. About Track 16: Prostate Cancer Prostate cancer remains one of the most frequently diagnosed malignancies among men worldwide and continues to represent a major global healthcare challenge. Rapid advancements in genomic medicine...